Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
PROGNOSTIC EVALUATION OF SEVERE SEPSIS AND SEPTIC SHOCK. PROCALCITONIN VERSUS DELTA SOFA
1 other identifier
observational
128
1 country
2
Brief Summary
The purpose of this study is to compare the tendency of plasma concentration and clearance of procalcitonin in the first 24 and 48 hours of management of patients with severe sepsis and septic shock with another marker of early prognosis represented by 48 hours delta sofa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 24, 2013
CompletedFirst Posted
Study publicly available on registry
April 26, 2013
CompletedApril 26, 2013
March 1, 2013
8 months
April 24, 2013
April 25, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MORTALITY
28 DAYS
Study Arms (2)
PROCALCITONIN
DELTA SOFA
Eligibility Criteria
Adult patients with severe sepsis and septic shock admitted to a multidisciplinary ICU
You may qualify if:
- Adult patients admitted to the ICU
- severe sepsis and septic shock
You may not qualify if:
- Children
- Pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital Sao Domingos
São Luís, Maranhão, 65060-642, Brazil
Hospital Sao Domingos
São Luís, Maranhão, 65060-642, Brazil
Related Publications (1)
de Azevedo JR, Torres OJ, Beraldi RA, Ribas CA, Malafaia O. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Delta Sequential Organ Failure Assessment. J Crit Care. 2015 Feb;30(1):219.e9-12. doi: 10.1016/j.jcrc.2014.08.018. Epub 2014 Sep 10.
PMID: 25241933DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD. COORDINATOR. ICU.
Study Record Dates
First Submitted
April 24, 2013
First Posted
April 26, 2013
Study Start
May 1, 2012
Primary Completion
January 1, 2013
Last Updated
April 26, 2013
Record last verified: 2013-03